Serge Saxonov - Feb 22, 2024 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Stock symbol
TXG
Transactions as of
Feb 22, 2024
Transactions value $
-$130,737
Form type
4
Date filed
2/26/2024, 04:13 PM
Previous filing
Feb 20, 2024
Next filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale -$131K -2.82K -0.33% $46.34 848K Feb 22, 2024 Direct F1
holding TXG Class A Common Stock 27 Feb 22, 2024 See footnote F2
holding TXG Class A Common Stock 870 Feb 22, 2024 See footnote F3
holding TXG Class A Common Stock 183K Feb 22, 2024 See footnote F4
holding TXG Class A Common Stock 16.3K Feb 22, 2024 See footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F4 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F5 The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.